Ring Therapeutics Funding: $117M Raised, Series B (2021)
Ring Therapeutics is based in Cambridge, MA. It has raised $117M in total funding. Latest round: Series B.
Ring Therapeutics funding overview
Ring Therapeutics is based in Cambridge, MA. Ring Therapeutics has raised $117M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in July 2021. The round record for Ring Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Invus, Altitude Life Science Ventures, Partners Investment, UPMC Enterprises, T. Rowe Price Associates, Inc., Flagship Pioneering. 6 distinct backers are named across the disclosed rounds.
Ring Therapeutics at a glance
Total raised
$117M
Latest round
Series B
Latest round date
July 2021
Headquarters
Cambridge, MA
Notable investors
Invus, Altitude Life Science Ventures, Partners Investment, UPMC Enterprises, T. Rowe Price Associates, Inc., Flagship Pioneering
Frequently asked about Ring Therapeutics funding
How much has Ring Therapeutics raised?
Ring Therapeutics has raised $117M in total disclosed funding across the rounds on record.
Who has invested in Ring Therapeutics?
Invus, Altitude Life Science Ventures, Partners Investment, UPMC Enterprises, T. Rowe Price Associates, Inc., Flagship Pioneering are named among the investors backing Ring Therapeutics.
What was the latest Ring Therapeutics funding round?
The most recent disclosed round is a Series B, announced in July 2021.
Where is Ring Therapeutics based?
Ring Therapeutics is based in Cambridge, MA.
When did Ring Therapeutics last raise?
The last disclosed Ring Therapeutics round closed in July 2021 at Series B.
We update the Ring Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
